NCT00429377
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- Chubu Region, Japan
- Hokkaido Region, Japan
- Hokuriku Region, Japan
- Kansai Region, Japan
Clinical trial condition
Lupus Nephritis
Explore clinical trials studying Lupus Nephritis. Study availability and eligibility vary by location and protocol.
219 public trials
78 recruiting studies
Lupus Nephritis trial results
NCT00035308
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Rheumatology Associates of North Alabama Huntsville, Alabama, United States
- Montgomery Rheumatology Associates Montgomery, Alabama, United States
- Arizona Arthritis & Rheumatology Paradise Valley, Arizona, United States
Completed
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
NCT00268567
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
- Locations
-
- Renal Division, Peking University First Hospital Beijing, China
- Department of Nephrology, Kidney Center and key Lab of PLA, Chinese General Hospital of PLA Beijing, China
- Division of Nephrology, Nanfang Hospital, Southern Medical University Guangzhou, China
- Renal Division, the First Affiliated Hospital, Sun Yat-sen University Guangzhou, China
Active, Not Recruiting
An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus
NCT05798117
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
- Locations
-
- Novartis Investigative Site Clayton, Victoria, Australia
- Novartis Investigative Site Paris, France
- Novartis Investigative Site Pessac, France
- Novartis Investigative Site Strasbourg, France
Active, Not Recruiting
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
NCT04221477
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Medical Center Birmingham, Alabama, United States
- Wallace Rheumatic Study Center Beverly Hills, California, United States
- Kaiser Permanente - Fontana Fontana, California, United States
- Kaiser Permanente - San Francisco Medical Center San Francisco, California, United States
Active, Not Recruiting
Daratumumab to Treat Active Lupus Nephritis
NCT04868838
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
NCT06544330
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Feinstein Institutes for Medical Research Manhasset, New York, United States
- Columbia University Irving Medical Center New York, United States
Active, Not Recruiting
Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis
NCT07678203
- Conditions
- Autoimmune Diseases, Chronic Disease, Chronic Kidney Disease, +21 more
- Locations
-
- Nuevo Hospital Civil de Guadalajara "Dr. Juan I. Menchaca". Guadalajara, Jalisco, Mexico
Active, Not Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
NCT05126277
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- University Of Alabama Birmingham, Alabama, United States
- Advanced Medical Research La Palma, California, United States
- University of California Irvine Orange, California, United States
- School Of Medicine Sacramento, California, United States
Active, Not Recruiting
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
NCT05138133
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- Research Site Glendale, Arizona, United States
- Research Site La Palma, California, United States
- Research Site Los Angeles, California, United States
- Research Site Upland, California, United States